Tuesday, 22 June 2010

Sativex for MS-related spasticity

It has been a long haul, but finally another option for people with MS-related spasticity.

Click here for press release

The signficance of this license cannot be under estimated; particularly as the registration study will probably set a precedent for how spasticity studies are done in the future. The Ashworth Scale has had its day and is seriously flawed as an outcome measure. This result can also be viewed as a victory for patient-related outcome measures or PROMS.

No comments:

Post a Comment

Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.